<?xml version="1.0" encoding="UTF-8"?>
<data xmlns="http://www.aopkb.org/aop-xml">
  <biological-object id="f1909f8c-daa9-4338-aa7a-b54425baa269">
    <source-id>PR:000001193</source-id>
    <source>PR</source>
    <name>beta-2 adrenergic receptor</name>
  </biological-object>
  <biological-process id="b4f04496-8359-4d9a-b9af-6fe5d90f2f3d">
    <source-id>GO:0004941</source-id>
    <source>GO</source>
    <name>beta2-adrenergic receptor activity</name>
  </biological-process>
  <biological-action id="e0609f6b-6622-482f-a025-b0e34443996a">
    <source-id>1</source-id>
    <source>WIKI</source>
    <name>increased</name>
  </biological-action>
  <key-event id="1fbfa9ee-492e-4784-b859-19e6f99b968b">
    <title>Increased activity, beta-2 adrenergic receptor</title>
    <short-name>Increased activity, beta-2 adrenergic receptor</short-name>
    <biological-organization-level>Molecular</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <cell-term>
      <source-id>CL:0000255</source-id>
      <source>CL</source>
      <name>eukaryotic cell</name>
    </cell-term>
    <applicability>
    </applicability>
    <biological-events>
      <biological-event object-id="f1909f8c-daa9-4338-aa7a-b54425baa269" process-id="b4f04496-8359-4d9a-b9af-6fe5d90f2f3d" action-id="e0609f6b-6622-482f-a025-b0e34443996a"/>
    </biological-events>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2016-11-29T18:41:28</creation-timestamp>
    <last-modification-timestamp>2017-09-16T10:17:04</last-modification-timestamp>
  </key-event>
  <key-event id="a1e98e39-61c2-416b-a268-1f9526dbc43e">
    <title> Abnormal Cardiac Structure and Function</title>
    <short-name> Abnormal Cardiac Structure and Function</short-name>
    <biological-organization-level>Organ</biological-organization-level>
    <description></description>
    <measurement-methodology></measurement-methodology>
    <evidence-supporting-taxonomic-applicability></evidence-supporting-taxonomic-applicability>
    <applicability>
    </applicability>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2023-07-31T00:59:00</creation-timestamp>
    <last-modification-timestamp>2023-07-31T00:59:00</last-modification-timestamp>
  </key-event>
  <aop id="69fe0d8b-4c9a-496d-b2cd-e782fe1ff2e7">
    <title>β2-Receptor agonist leading to Cardiomyopathy</title>
    <short-name>Overstimulation of β2-Receptor,  Cardiomyopathy</short-name>
    <point-of-contact>Young Jun Kim</point-of-contact>
    <authors></authors>
    <coaches>
    </coaches>
    <external_links>
    </external_links>
    <status>
      <wiki-license>BY-SA</wiki-license>
    </status>
    <oecd-project/>
    <handbook-version>2.7</handbook-version>
    <abstract>&lt;p&gt;Stimulation of &amp;beta;2-adrenergic receptors, under pathological conditions, can contribute to the development of cardiomyopathy. While &amp;beta;2-receptors normally regulate myocardial contraction through Gs protein signaling, chronic or excessive activation leads to maladaptive changes in the myocardium. Sustained stimulation results in calcium overload, oxidative stress, and mitochondrial dysfunction, triggering apoptosis and promoting myocardial remodeling, including hypertrophy and fibrosis. Conditions such as stress cardiomyopathy (Takotsubo syndrome) and chronic sympathetic overactivation highlight the detrimental effects of &amp;beta;2-receptor overstimulation. Excessive catecholamine release or overuse of &amp;beta;2-selective agonists further exacerbates myocardial stress, progressing to structural and functional cardiac deterioration. Clinical manifestations include dilated cardiomyopathy, hypertrophic remodeling, and arrhythmias. Although &amp;beta;2-receptor activation is physiologically beneficial in acute settings, prolonged overstimulation can contribute to cardiomyopathy through mechanisms of calcium dysregulation and maladaptive remodeling.&lt;/p&gt;
</abstract>
    <molecular-initiating-event key-event-id="1fbfa9ee-492e-4784-b859-19e6f99b968b">
      <evidence-supporting-chemical-initiation></evidence-supporting-chemical-initiation>
    </molecular-initiating-event>
    <adverse-outcome key-event-id="a1e98e39-61c2-416b-a268-1f9526dbc43e">
      <examples/>
    </adverse-outcome>
    <applicability>
    </applicability>
    <overall-assessment>
      <description></description>
      <applicability></applicability>
      <key-event-essentiality-summary></key-event-essentiality-summary>
      <weight-of-evidence-summary></weight-of-evidence-summary>
      <known-modulating-factors>&lt;div&gt;
&lt;table class="table table-bordered table-fullwidth"&gt;
	&lt;thead&gt;
		&lt;tr&gt;
			&lt;th&gt;Modulating Factor (MF)&lt;/th&gt;
			&lt;th&gt;Influence or Outcome&lt;/th&gt;
			&lt;th&gt;KER(s) involved&lt;/th&gt;
		&lt;/tr&gt;
	&lt;/thead&gt;
	&lt;tbody&gt;
		&lt;tr&gt;
			&lt;td&gt;&amp;nbsp;&lt;/td&gt;
			&lt;td&gt;&amp;nbsp;&lt;/td&gt;
			&lt;td&gt;&amp;nbsp;&lt;/td&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;
&lt;/div&gt;
</known-modulating-factors>
      <quantitative-considerations></quantitative-considerations>
    </overall-assessment>
    <potential-applications></potential-applications>
    <references></references>
    <source>AOPWiki</source>
    <creation-timestamp>2024-11-19T12:40:35</creation-timestamp>
    <last-modification-timestamp>2024-11-22T10:34:11</last-modification-timestamp>
  </aop>
  <vendor-specific id="4c1d414c-9fda-4000-8059-90472ed33684" name="AopWiki" version="2026-05-14 01:24:05 +0000">
    <biological-process-reference id="b4f04496-8359-4d9a-b9af-6fe5d90f2f3d" aop-wiki-id="26095"/>
    <biological-action-reference id="e0609f6b-6622-482f-a025-b0e34443996a" aop-wiki-id="1"/>
    <biological-object-reference id="f1909f8c-daa9-4338-aa7a-b54425baa269" aop-wiki-id="143334"/>
    <key-event-reference id="1fbfa9ee-492e-4784-b859-19e6f99b968b" aop-wiki-id="1039"/>
    <key-event-reference id="a1e98e39-61c2-416b-a268-1f9526dbc43e" aop-wiki-id="2157"/>
    <aop-reference id="69fe0d8b-4c9a-496d-b2cd-e782fe1ff2e7" aop-wiki-id="557"/>
  </vendor-specific>
</data>
